Agensys

About:

Agensys offers products to treat various tumors as well as prostate, pancreatic and bladder cancers.

Top Investors: OrbiMed, Silicon Valley Bank, Alta Partners, JAFCO Asia, Nextech Invest

Description:

Agensys a biotechnology company, engages in the research and development of therapeutic human monoclonal antibodies and antibody drug conjugates for the treatment of cancer. It offers products to treat various tumors, as well as prostate, pancreatic, and bladder cancers. The company, formerly known as UroGenesys, was founded in 1997 and is based in Santa Monica, California. As of December 18, 2007, Agensys, Inc. operates as a subsidiary of Astellas Pharma US, Inc.

Total Funding Amount:

$106M

Headquarters Location:

Santa Monica, California, United States

Founded Date:

1997-01-01

Founders:

Arie Belldegrun, Donald B. Rice, Jean deKernion

Number of Employees:

251-500

Last Funding Date:

2007-07-12

IPO Status:

Private

Industries: